Trial Profile
Late phase II clinical study of intra-arterial chemotherapy using SM-11355 in patients with hepatocellular carcinoma (HCC) .
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Jun 2016
Price :
$35
*
At a glance
- Drugs Miriplatin (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- Sponsors Sumitomo Dainippon Pharma
- 14 Jun 2016 New trial record